Performant/$PHLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Performant
Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.
Ticker
$PHLT
Sector
Primary listing
Employees
964
Headquarters
Website
Performant Metrics
BasicAdvanced
$599M
-
-$0.01
0.41
-
Price and volume
Market cap
$599M
Beta
0.41
52-week high
$7.74
52-week low
$2.17
Average daily volume
1.8M
Financial strength
Current ratio
2.641
Quick ratio
2.443
Long term debt to equity
10.392
Total debt to equity
11.044
Interest coverage (TTM)
-0.04%
Profitability
EBITDA (TTM)
1.852
Gross margin (TTM)
23.66%
Net profit margin (TTM)
-0.64%
Operating margin (TTM)
-0.03%
Effective tax rate (TTM)
-1.96%
Revenue per employee (TTM)
$140,000
Management effectiveness
Return on assets (TTM)
-0.03%
Return on equity (TTM)
-1.12%
Valuation
Price to revenue (TTM)
4.319
Price to book
7.28
Price to tangible book (TTM)
17.17
Price to free cash flow (TTM)
-1,345.403
Free cash flow yield (TTM)
-0.07%
Free cash flow per share (TTM)
-0.006
Growth
Revenue change (TTM)
15.21%
Earnings per share change (TTM)
-86.30%
3-year revenue growth (CAGR)
6.75%
10-year revenue growth (CAGR)
-1.46%
3-year earnings per share growth (CAGR)
-56.17%
10-year earnings per share growth (CAGR)
-21.82%
What the Analysts think about Performant
Analyst ratings (Buy, Hold, Sell) for Performant stock.
Bulls say / Bears say
Total revenue rose 22 percent year-over-year to $33.3 million in Q1 2025, with healthcare revenue up 29 percent to $33.2 million, reflecting strong demand for Performant’s payment integrity services (GuruFocus).
Adjusted EBITDA turned positive at $3.3 million in Q1 2025 versus a negative $1.2 million in Q1 2024, marking a key inflection toward profitability (GuruFocus).
Analyst coverage has improved with JMP Securities initiating Market Outperform and a consensus price target implying over 66 percent upside, signaling Wall Street confidence in the company’s growth trajectory (Fintel)
Full-year 2024 net loss widened to $9.9 million from $7.5 million in 2023, underscoring persistent unprofitability despite revenue gains (Business Wire).
Ramp-up costs related to the New York State Medicaid RAC contract and other implementations—estimated at $4.5–5.5 million in net costs plus $1–2 million in Project Turing spending—are likely to pressure margins through 2025 (EarningsCall.biz).
Cash, cash equivalents and restricted cash stood at only $9.3 million as of December 31, 2024, which may be insufficient to cover upcoming implementation costs and operating expenses without additional financing (Business Wire)
Data summarised monthly by Lightyear AI. Last updated on 1 Aug 2025.
Performant Financial Performance
Revenues and expenses
Performant Earnings Performance
Company profitability
Performant News
AllArticlesVideos
Shareholder Alert: The Ademi Firm Investigates Whether Performant Healthcare Inc. Is Obtaining a Fair Price for Its Public Shareholders
Business Wire·2 weeks ago
PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc. - PHLT
Business Wire·3 weeks ago
PHLT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Performant Healthcare, Inc. Is Fair to Shareholders
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Performant stock?
Performant (PHLT) has a market cap of $599M as of August 23, 2025.
What is the P/E ratio for Performant stock?
The price to earnings (P/E) ratio for Performant (PHLT) stock is 0 as of August 23, 2025.
Does Performant stock pay dividends?
No, Performant (PHLT) stock does not pay dividends to its shareholders as of August 23, 2025.
When is the next Performant dividend payment date?
Performant (PHLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Performant?
Performant (PHLT) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.